Performance of the Diagnostic Value of Bone Age Assessment Software Based on Deep Learning in Chinese Children
1 other identifier
observational
1,000
1 country
1
Brief Summary
High accuracy and precision bone age assessment is very important for the diagnosis and treatment monitoring of various pediatric diseases. The commonly used bone age assessment methods include GP atlas, TW3 score and Zhonghua 05. GP method is to compare wrist X-ray films with atlas reference X-ray films. Its main disadvantages are strong subjectivity and long atlas standard interval. Different from GP method, TW3 method is to grade and score each bone, add each epiphyseal score to calculate the total score of bone maturity, and obtain the corresponding final bone age value. Although TW3 scoring method is relatively accurate, it is complex and time-consuming, and there is great variability among evaluators. In order to evaluate bone age more efficiently and accurately, a method based on computer image automatic recognition technology can help to overcome these problems. In this study, 1000 children aged 1-18 in 5 hospitals are selected as the research objects. After taking bone age films with bone age instrument, the film reading results and evaluation time of AI Group, artificial group and standard group are recorded. One month later, the artificial group re-analyzes 1000 films with the assistance of AI system, and the evaluation time is recorded. Finally, the accuracy and time difference of artificial group, AI Group, artificial combined AI Group and standard group are compared. The purpose of this study is to use the most advanced artificial intelligence deep learning bone age evaluation software to explore the value of bone age instrument to improve the accuracy and diagnostic efficiency of bone age evaluation by pediatricians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2021
CompletedFirst Posted
Study publicly available on registry
November 30, 2021
CompletedStudy Start
First participant enrolled
February 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 20, 2023
April 1, 2023
2.9 years
November 11, 2021
April 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bone age
The mean absolute error (MAE) and root mean square error (RSME) between the evaluation bone age results of different groups
one month
Interventions
Bone age films were taken by X-ray bone age instrument
Eligibility Criteria
Children aged 1-18 who need bone age assessment
You may qualify if:
- Children aged 1 to 18 years.
- Clinical diagnosis of requiring bone age examination.
You may not qualify if:
- There are obstructions or implants in the wrist bone, such as metal.
- Poor resolution, which affects the observation of bone characteristics.
- Poor shooting position of the wrist due to various reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tongji Hospitallead
- Changchun GeneScience Pharmaceutical Co., Ltd.collaborator
Study Sites (1)
Tongji Hospital Tongji Medical College of Hust
Wuhan, Hubei, China
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
xiumin wang, director
Shanghai Children's Medical Center
- PRINCIPAL INVESTIGATOR
xinran cheng, director
Chendu Women's and children's central hospital
- PRINCIPAL INVESTIGATOR
xiaobo chen, director
Children's Hospital of The Capital Institute of Pediatrics
- PRINCIPAL INVESTIGATOR
ZE SU, director
Shenzhen Children's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Pediatrics
Study Record Dates
First Submitted
November 11, 2021
First Posted
November 30, 2021
Study Start
February 21, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 20, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share